On 12 February 2020, the World Health Organization (WHO) reaffirmed its recommendation that individuals exposed to the novel coronavirus should observe a 14‑day quarantine. The decision came after the agency examined a pre‑print study from China that suggested the virus might incubate for as long as 24 days.
Dr Michael Ryan, who heads WHO’s Health Emergencies Programme, addressed the matter in a press briefing. He explained that unusually long incubation periods reported for other diseases—Ebola, for example—are often linked to multiple exposures rather than a single infection event. “What we have seen with Ebola is that sometimes a long incubation period can be due to a double exposure,” Ryan said, adding that the 24‑day outlier in the Chinese data requires further validation before any policy shift could be justified.
The study in question, titled “Clinical characteristics of 2019 novel coronavirus infection in China,” was led by Chinese epidemiologist and pulmonologist Zhong Nanshan and posted on the pre‑print server medRxiv. The platform clearly marks its content as un‑reviewed research, warning that such papers should not be used to direct clinical practice. An analysis of 1,099 patients across China reported a median incubation of three days, with a range extending from zero to 24 days. While the 24‑day figure attracted media attention, health experts cautioned against drawing conclusions from a single data point.
Medical educator Dr Roger Seheult, known for his MedCram YouTube channel, offered a technical perspective on why the 24‑day number could be misleading. He suggested that a second, possibly asymptomatic infection occurring after the initial exposure might extend the time to symptom onset, creating the appearance of a prolonged incubation. “There’s an infection that occurs on day 0 with an incubation of 10 days, and then another repeated one that may not cause symptoms until later,” Seheult explained. “The total adds up to 24 days, but it does not represent the incubation period of a single infection.”
The WHO’s refusal to alter its guidance underscores the role of peer review in shaping public‑health policies. Although the Chinese manuscript draws on a sizable dataset, it has not undergone the rigorous evaluation customary for scientific publication. MedRxiv itself notes that pre‑print articles “report new medical research that has yet to be evaluated” and should not inform clinical decisions.
At the time of the WHO’s statement, the outbreak had resulted in more than 1,000 deaths in China and roughly 40,000 confirmed cases worldwide. WHO officials continued to coordinate international efforts on therapeutics and vaccine development, while urging public‑health authorities to keep the 14‑day quarantine as the standard precaution for anyone potentially exposed.
Health agencies also reminded the public that individuals developing symptoms such as fever, cough, or breathing difficulty should seek medical attention promptly. The organization’s stance reflects a cautious approach amid a rapidly evolving situation, emphasizing reliance on verified, peer‑reviewed evidence when forming containment strategies.
While Chinese researchers have contributed valuable data to the global understanding of the virus, the WHO’s position highlights the necessity of robust scientific validation before altering established public‑health measures. The international medical community remains focused on containing the spread and mitigating the impact of the novel coronavirus.
